Fuse Biotherapeutics

Fuse Biotherapeutics is developing immune-modifying therapies to treat cancer. Immune responses consist of multiple steps to ensure that it effectively deals with various situations within the body. FuseBio is creating therapies that potentiate two of the major categories of the immune system: innate and adaptive immunity. In this manner, FuseBio hopes to attain potent responses to danger, such as against cancerous cells, without natural breaks in the system that spare healthy tissue using their technology.

Jobs: